← SynDRA
PD 161570
SynDRA canonical compound SYN0147010 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | FGFR1 |
|---|
| Mechanism of action | FGFR inhibitor |
|---|
Cross-references
Synonyms
- RefChem:858783
- pd161570
- PD-161570;PD161570
- MKVMEJKNLUWFSQ-UHFFFAOYSA-N
- MFCD16618403
- 6-arylpyrido[2,3-d]pyrimidine deriv. 33
- PF-1480232
- C26H35Cl2N7O
- BDBM3451
- orb1305719
- SCHEMBL4301366
- SCHEMBL29375761
- SCHEMBL30368635
- GLXC-20192
- HMS3262A10
- HMS3414B11
- HMS3678B11
- EX-A5294
- Tox21_500724
- AKOS024457772
- CCG-222028
- EBC-497082
- FP26775
- NCGC00261409-01
- NCGC00370903-01
- NCGC00370903-02
- DA-66527
- MS-29836
- HY-100434
- CS-0018918
- P2531
- PD-161570?
- E79105
- T23127
- PD-161570, >=98% (HPLC)
- BRD-K97152684-001-01-9
Look up PD 161570 in the interactive SynDRA portal →